Seidel-Glätzer, AndreaUniversität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
- Hundemer, Michael (3)
- Weinhold, Niels (3)
- Müller-Tidow, Carsten (2)
- Mai, Elias K. (2)
- Hillengaß, Jens (2)
- Burghaus, Ina (1)
- Mechtersheimer, Gunhild (1)
- Goeppert, Benjamin (1)
- Riffel, Johannes (1)
- Burhenne, Jürgen (1)
- Stoll, Felicitas E. (1)
- Kriegsmann, Katharina (1)
- Weiß, Johanna (1)
- André, Florian (1)
- Daniel, Volker (1)
- Blank, Antje (1)
- Sauter, Max (1)
- Awwad, Mohamed (1)
- Poos, Alexandra (1)
- Kunz, Christina (1)
- Rose, Peter (1)
- Schlenzka, Jana (1)
- Ton, Gigi Nu Hoang Quy (1)
- Haefeli, Walter E. (1)
- Göring, Oliver (1)
- Becker, Nicole (1)
- Stenzinger, Albrecht (1)
- Giesen, Nicola (1)
Co-author (external)
Publications in heiBIB 
- Kriegsmann, Katharina: CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients : results from the GMMG-HD6 multicenter phase III study / Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H. S. Awwad, Axel Benner, Uta Bertsch, Britta B… , 2024. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 38(2024), 7, Seite 1621-1625
DOI: 10.1038/s41375-024-02290-y
- Mai, Elias K.: Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial / Elias K Mai, Hartmut Goldschmidt, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Julia Krzyk… , February 2024. - 13 S.
In: The lancet, ISSN 2352-3026. 11(2024), 2, Seite e101-e113
DOI: 10.1016/S2352-3026(23)00366-6
- Giesen, Nicola: A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma / Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel… , April 6, 2023. - 6 S.
In: Blood, ISSN 1528-0020. 141(2023), 14 vom: Apr., Seite 1685-1690
DOI: 10.1182/blood.2022017789
- Stoll, Felicitas E.: Metabolic effect of blocking sodium-taurocholate co-transporting polypeptide in hypercholesterolemic humans with a twelve-week course of bulevirtide : n exploratory phase I clinical trial / Felicitas Stoll, Andrea Seidel-Glätzer, Ina Burghaus, Oliver Göring, Max Sauter, Peter Rose, Volker … , 14 December 2022. - 16 S.
In: International journal of molecular sciences, ISSN 1422-0067. 23(2022), 24, Artikel-ID 15924, Seite 1-16
DOI: 10.3390/ijms232415924
- Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… . -
London: BioMed Central, 2019. - 1 Online-Ressource (11 Seiten)
- Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… , 28 May 2019. - 11 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 504, 11 Seiten
DOI: 10.1186/s12885-019-5600-x
